Search Results - "Guchelaar, Henk-Jan"

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply.

Authors: Swen, Jesse J Manson, Lisanne E N Böhringer, Stefan et al.

Source: Lancet. Jun2023, Vol. 401 Issue 10391, p1851-1852. 2p.

Subjects: Authors

Pre‐Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta‐Analysis and Recommendation.

Authors: Goedhart, Tessa Guchelaar, Henk‐Jan

Source: CTS: Clinical & Translational Science. Jan2026, Vol. 19 Issue 1, p1-11. 11p.

Author Index.

Source: Xenotransplantation. Sep/Oct2009, Vol. 16 Issue 5, p442-462. 21p.

Reply to: Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing.

Authors: Guchelaar, Henk‐Jan Swen, Jesse

Source: Basic & Clinical Pharmacology & Toxicology. Oct2023, Vol. 133 Issue 4, p400-401. 2p.

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.

Authors: Brokaar, Edwin Knikman, Jonathan Visser, Loes et al.

Source: Fundamental & Clinical Pharmacology. Mar2025, Vol. 39 Issue 2, p1-11. 11p.

Validation of transcriptome signature reversion for drug repurposing in oncology.

Authors: Koudijs, Karel K M Böhringer, Stefan Guchelaar, Henk-Jan

Source: Briefings in Bioinformatics; Jan2023, Vol. 24 Issue 1, p1-10, 10p

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole.

Authors: Klomp, Sylvia D. Veringa, Anette Alffenaar, Jan‐Willem C. et al.

Source: CTS: Clinical & Translational Science. Jul2024, Vol. 17 Issue 7, p1-10. 10p.

Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics.

Authors: Van Daele, Ruth Debaveye, Yves Vos, Robin et al.

Source: Mycoses. Sep2021, Vol. 64 Issue 9, p1111-1116. 6p.

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib.

Authors: Yin, Anyue Veerman, G. D. Marijn van Hasselt, Johan G. C. et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Apr2024, Vol. 13 Issue 4, p612-623. 12p.

This result is not displayed to guests.
Login for full access.

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Authors: Wang, Yan Bukkems, Laura H. ter Heine, Rob et al.

Source: Clinical Pharmacokinetics. Apr2026, Vol. 65 Issue 4, p633-633. 1p.

This result is not displayed to guests.
Login for full access.

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease.

Authors: Sluiter, Reinier L Marrewijk, Corine Van Jong, Dirk De et al.

Source: Journal of Crohn's & Colitis. Jul2019, Vol. 13 Issue 7, p838-845. 8p.

Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.

Authors: Yin, Anyue van Hasselt, Johan G. C. Guchelaar, Henk-Jan et al.

Source: Scientific Reports. 3/10/2022, Vol. 12 Issue 1, p1-14. 14p.

Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool.

Authors: van der Stoep, M. Y. Eileen C. Berghuis, Dagmar Bredius, Robbert G. M. et al.

Source: Scientific Reports. 9/27/2021, Vol. 11 Issue 1, p1-9. 9p.

5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.

Authors: Vermes, Andras Guchelaar, Henk-Jan

Source: Fundamental & Clinical Pharmacology. Feb2002, Vol. 16 Issue 1, p39. 9p.

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.

Authors: Houtsma, Danny de Groot, Stefanie Baak-Pablo, Renee et al.

Source: Scientific Reports. 2/5/2021, Vol. 11 Issue 1, p1-8. 8p.

Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.

Authors: Yin, Anyue van Hasselt, Johan G. C. Guchelaar, Henk-Jan et al.

Source: Scientific Reports. 3/22/2022, Vol. 12 Issue 1, p1-2. 2p.

Epidemiology of Extracutaneous Melanoma in the Netherlands.

Authors: Koomen, Els R. De Vries, Esther Kempen, Leon C. van et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jun2010, Vol. 19 Issue 6, p1453-1459.

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.

Authors: Caudle, Kelly E. Sangkuhl, Katrin Whirl‐Carrillo, Michelle et al.

Source: CTS: Clinical & Translational Science. Jan2020, Vol. 13 Issue 1, p116-124. 9p.